Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Fibroblast-specific IKK-β deficiency ameliorates angiotensin II–induced adverse cardiac remodeling in mice
Weiwei Lu, Zhaojie Meng, Rebecca Hernandez, Changcheng Zhou
Weiwei Lu, Zhaojie Meng, Rebecca Hernandez, Changcheng Zhou
View: Text | PDF
Research Article Cardiology

Fibroblast-specific IKK-β deficiency ameliorates angiotensin II–induced adverse cardiac remodeling in mice

  • Text
  • PDF
Abstract

Cardiac inflammation and fibrosis contribute significantly to hypertension-related adverse cardiac remodeling. IκB kinase β (IKK-β), a central coordinator of inflammation through activation of NF-κB, has been demonstrated as a key molecular link between inflammation and cardiovascular disease. However, the cell-specific contribution of IKK-β signaling toward adverse cardiac remodeling remains elusive. Cardiac fibroblasts are one of the most populous nonmyocyte cell types in the heart that play a key role in mediating cardiac fibrosis and remodeling. To investigate the function of fibroblast IKK-β, we generated inducible fibroblast-specific IKK-β–deficient mice. Here, we report an important role of IKK-β in the regulation of fibroblast functions and cardiac remodeling. Fibroblast-specific IKK-β–deficient male mice were protected from angiotensin II–induced cardiac hypertrophy, fibrosis, and macrophage infiltration. Ablation of fibroblast IKK-β inhibited angiotensin II–stimulated fibroblast proinflammatory and profibrogenic responses, leading to ameliorated cardiac remodeling and improved cardiac function in IKK-β–deficient mice. Findings from this study establish fibroblast IKK-β as a key factor regulating cardiac fibrosis and function in hypertension-related cardiac remodeling.

Authors

Weiwei Lu, Zhaojie Meng, Rebecca Hernandez, Changcheng Zhou

×

Figure 6

Deficiency of IKK-β decreases angiotensin II–induced cardiac fibroblast proliferation.

Options: View larger image (or click on image) Download as PowerPoint
Deficiency of IKK-β decreases angiotensin II–induced cardiac fibroblast ...
Eight-week-old male IKKβfl/fl and IKKβΔFib mice were i.p. injected with 2 mg tamoxifen per day for 5 days. At the age of 10 weeks, those mice were infused with 1000 ng/kg/min of angiotensin II (Ang II) or vehicle control for 1 week. (A) Representative images of immunofluorescence staining (top) and the quantification (bottom, normalized to the number of DAPI-stained cells) of Ki-67–positive cells in the hearts of IKKβfl/fl and IKKβΔFib mice (n = 3–4, 2-way ANOVA; *P < 0.05, ***P < 0.001; scale bar: 50 μm). (B and C) qPCR analysis of the proliferation-related genes (B) and apoptotic genes (C) in the hearts of IKKβfl/fl and IKKβΔFib mice (n = 4–5; 2-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001). (D) Growth-arrested fibroblasts isolated from the hearts of IKKβfl/fl and IKKβΔFib mice were stimulated with 10–6 M of Ang II or vehicle control for 24 hours, and the amount of [3H] thymidine incorporated into DNA of the cells was measured (n = 4; 2-way ANOVA; ***P < 0.001).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts